Clinical Trial Update: Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunomodulatory effects of dexamethasone, tocilizumab, and anakinra during controlled experimental endotoxemia in humans;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Anakinra (anakinra)
• DEXAMETHASONE (Dexamethasone)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Sepsis, Neuroinflammatory Response | Phase 4 | Status: RECRUITING